IBC Cayuse Migration Starting October 1st 2026
We are preparing to transition all existing IBC protocols from the old MyProtocol system to Cayuse. This will be a soft migration, so you do not need to do anything right now. We will begin the migration in phases, and I will contact you directly when it is time for your protocol to be moved.
For existing MyProtocol protocols, I will create a “shelled” protocol in Cayuse and transfer as much of the existing information as possible. Because the Cayuse IBC form is different from the MyProtocol form, this will not be a simple copy-and-paste process. Once I have entered everything I can, you will receive an email asking you to go into Cayuse, complete any remaining sections, and review the information that has been entered. You will then need to certify the protocol on the Certifications page and submit it.
We will migrate a set number of protocols each month, beginning with protocols that were approved in 2023. This is also when we will begin implementing a three-year approval period for IBC protocols. The NIH has proposed changes that would move to a three-year expiration period. If that proposal is approved next year, existing five-year approval periods would not be grandfathered in. Because of this, we are implementing the three-year period as part of this migration rather than making another change later.
Not every migrated protocol will go through a full IBC review. A protocol will be sent to the full IBC for review if it contains new procedural changes, was originally approved in 2023, or involves recombinant DNA. Other protocols will be migrated and issued a new three-year approval without going through the full board review process.
You will receive an email from us once your migrated protocol has been approved. We will not be halting ongoing studies during this migration, as we did during the previous transition.
New Protocols and Amendments
Beginning October 1, all new IBC protocol submissions must be submitted through Cayuse. PIs will not have access to the Cayuse IBC system until October 1.
If you need to amend a protocol that is still in the old MyProtocol system, you will submit the protocol through Cayuse. Please include the old MyProtocol protocol number in the title of the new Cayuse protocol so that we can properly track the migration.
PI instructions for new submissions and for reviewing migrated protocols will be available on the IBC website beginning October 1. I will also send those instructions directly to PIs at that time.
We will also hold a one-hour webinar on October 1 at 11:00 a.m. to provide training on submitting protocols in Cayuse and to walk through what the review process will look like. The webinar will be recorded and posted to the IBC webpage afterward for anyone who is unable to attend.
We appreciate your patience as we work through this transition. We expect this migration to be much smoother than our previous system transition.
Understanding Biosafety and Containment Levels
Biosafety addresses the safe handling and containment of biohazardous material. It is meant to prevent lab-acquired infections and/or prevent release into agricultural or natural ecosystems.
Containment is achieved through the use of work practices, safety equipment, PPE and facility features.
Containment of biohazardous material is described by 4 biosafety levels: BSL-1, BSL-2, BSL-3, and BSL-4. The higher the number the more dangerous the material. Click below for a more detailed description of these levels.
Standards & Regulations
- Biosafety in Microbiological and Biomedical Laboratories (BMBL)
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
- Bloodborne Pathogens
- Commerce Control List
- EPA (approved disinfectants)
- Select Agents
- Dual Use Research of Concern
- NIH BSL-3 Lab Certification Requirements
2026 Meeting Schedule
Meetings are held on the third Wednesday of each month at 1:30 p.m. at 301 Research Blvd.
When possible and consistent with protection of privacy and proprietary interests, IBC meetings can be made available to the public.
For further information, please contact the IBC admin at IBC@research.msstate.edu.
| Deadline | Meeting Date |
| January 7 | January 21 |
| February 4 | February 18 |
| March 4 | March 18 |
| April 2 | April 15 |
| May 6 | May 20 |
| June 3 | June 17 |
| July 1 | July 15 |
| August 5 | August 19 |
| September 2 | September 16 |
| October 7 | October 21 |
| November 4 | November 18 |
| December 2 | December 16 |
In accordance with new NIH requirements, all institutions are now mandated to make their IBC meeting minutes publicly available. This effort aims to promote transparency and accountability in research involving biohazardous materials. As part of compliance, our meeting minutes will be accessible here.
For information on how to fill out an IBC application/registration or modification form, or to determine if one should be submitted, please review the FAQ page.
IBC Membership
The IBC is composed of university faculty and staff with expertise in microbiology, molecular biology, animal containment and plant containment. Two community members represent the interest of the surrounding community. Click below to see the current IBC roster.
IBC Standard Operating Procedures (SOPS)
The IBC adheres to SOPs in order to review research in a consistent and fair manner.
MSU Policy on Biosafety
Current IBC SOPs
- IBC Charter
- IBC-PP-004 Annual Executive Review of the IBC
- IBC-PP-005 General Public Comments in IBC Activities
- IBC-PP-006 Use of Consultants in IBC Application Review
- IBC-PP-007 Human Cell Line Policy
- IBC-PP-008 Admin Review of Human/Primate Cell Culture Use
- IBC-PP-009 IBC Application Annual Update/Modification/Termination
- IBC-PP-011 IBC Member/Consultant COI
- IBC-PP-012 IBC Application Submission, Review and Approval
- IBC-PP-014 Confidentiality of IBC Deliberations
- IBC-PP-015 IBC Application Appeals by PI
- IBC-PP-016 Incident Reporting to Federal Agencies
- IBC-PP-017 IBC Member Training
- IBC-PP-018 Annual Report to NIH OBA
- IBC-PP-019_Autoclave Verification Program_2024
- IBC-PP-024 Public Request and Redaction of IBC Minutes
- IBC-PP-027 IBC Chair Duties
- IBC-PP-028 Suspension/Termination of Previously Approved Research
- IBC-PP-029 IBC Chair Training
- IBC-PP-030 Annual Post Approval Monitoring
- IBC-PP-032 Expiration Dates for IBC Applications
- IBC-PP-033 Edwardsiella ictaluri Biosafety Level Recommendation
- IBC-PP-034 Visitors during IBC Meeting
- IBC-PP-036 Incidents and Investigations of Incidents
- IBC-SOP-001 NIH Requirements
- IBC-SOP-002 Coordination of Institutional Oversight
- IBC-SOP-003 Animal Associated Risk Notification